임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 중· Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaNemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
협력: 머크(MSD)
- 2상모집 중· Lipoprotein(a)A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)
리드: 머크(MSD)
- 2상모집 중· Psoriatic ArthritisStudy to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
리드: 머크(MSD)
- 2상모집 중· Clear Cell Renal Cell CarcinomaPhase II Trial of Single Agent Belzutifan or Pembrolizumab Versus Combination as Neoadjuvant Therapy in Clear Cell Renal Cell Carcinoma (BLAZE)
협력: 머크(MSD)
- 2상모집 중· Squamous Non-small Cell Lung CancerA Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
리드: 머크(MSD) · 협력: 모더나
- 2상모집 중· Neoplasm MalignantA Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
리드: 머크(MSD)
- 2상모집 중· Radiographic Axial SpondyloarthritisA Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
리드: 머크(MSD)
- 2상모집 중· Colorectal Adenocarcinoma Metastatic in the LiverPembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma
협력: 머크(MSD)
- 2상모집 중· Malignant NeoplasmA Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
리드: 머크(MSD)
- 2상모집 중· Gastroesophageal Junction (GEJ) AdenocarcinomaAn Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma
협력: 머크(MSD)
- 2상모집 중· Early Alzheimer's DiseaseA Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
리드: 머크(MSD)
- 2상모집 중· Recurrent Triple-Negative Breast CancerPembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer
협력: 머크(MSD)
- 2상모집 중· Cutaneous SarcomaPembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma
협력: 머크(MSD)
- 2상모집 중· Non-small Cell Lung CancerProspective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
협력: 머크(MSD)
- 2상모집 중· MelanomaPLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients
협력: 머크(MSD)
- 2상모집 중· Malignant MelanomaA Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
리드: 머크(MSD)
- 2상모집 중· Carcinoma, Non-Small-Cell LungA Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
리드: 머크(MSD)
- 2상모집 중· Muscle Invasive Bladder Urothelial CarcinomaEnfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer
협력: 머크(MSD)
- 2상모집 중· Lung Neoplasm MalignantPembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)
리드: 머크(MSD)
- 2상모집 중· Urinary Bladder NeoplasmsA Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
리드: 머크(MSD) · 협력: 모더나
- 2상모집 중· Ovarian CancerNewly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
협력: 머크(MSD)
- 2상모집 중· Sinonasal Undifferentiated CarcinomaPembrolizumab in Locally Advanced Sinonasal Carcinoma
협력: 머크(MSD)
- 2상모집 중· Ovarian CancerBelzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
협력: 머크(MSD)
- 2상모집 중· Angiosarcoma of SkinPembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients
협력: 머크(MSD)
- 2상모집 중· Anal CancerStudy of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
협력: 머크(MSD)
- 2상모집 중· Urologic NeoplasmsCarboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
협력: 머크(MSD)
- 2상모집 중· Triple Negative Breast NeoplasmsNovel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer
협력: 머크(MSD)
- 2상모집 중· Billiary Track CancerPerioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers
협력: 머크(MSD)
- 2상모집 중· Relapsed Peripheral T-Cell LymphomaPembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma
협력: 머크(MSD)
- 2상모집 중· Renal Pelvis and Ureter Urothelial CarcinomaPembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer
협력: 머크(MSD)
- 2상모집 중· Esophageal AdenocarcinomaStudy of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
협력: 머크(MSD)
- 2상모집 중· Recurrent or Metastatic Solid TumorsA Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)
협력: 머크(MSD)
- 2상모집 중· Cytomegalovirus InfectionsOpen Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients
협력: 머크(MSD)
- 2상모집 중· Ovarian Clear Cell AdenocarcinomaPembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer
협력: 머크(MSD)
- 2상모집 중· Cervix CancerStudy of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)
협력: 머크(MSD)
- 2상모집 중· Advanced Solid TumorA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
협력: 머크(MSD)
- 2상모집 중· Esophageal CancerA Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
협력: 머크(MSD), 로슈
- 2상모집 중· Castrate Resistant Prostate CancerPembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
협력: 머크(MSD)
- 2상모집 중· Head and Neck Squamous Cell CarcinomaNeoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).
협력: 머크(MSD)
- 2상모집 중· Cutaneous T Cell LymphomaPembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
협력: 머크(MSD)
- 2상모집 중· TNBC - Triple-Negative Breast CancerReinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
협력: 머크(MSD)
- 2상모집 중· Primary Mediastinal Large B-cell Lymphoma (PMBCL)Pembro Plus CAR T-cell Therapy in R/R in PMBCL
협력: 머크(MSD)
- 2상모집 중· Oligometastatic Renal Cell CarcinomaA Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs)
협력: 머크(MSD)
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.